- Home
- VRNA
VRNA
Verona Pharma plc
as 03-31-2025 4:00pm EST
| Founded: | 2005 | Country: | United Kingdom |
| Employees: | N/A | City: | LONDON |
| Market Cap: | N/A | IPO Year: | 2017 |
| Target Price: | $66.83 | AVG Volume (30 days): | 1.1M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 6 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.16 | EPS Growth: | N/A |
| 52 Week Low/High: | $11.39 - $70.40 | Next Earning Date: | 05-08-2025 |
| Revenue: | $42,279,000 | Revenue Growth: | N/A |
| Revenue Growth (this year): | 639.52% | Revenue Growth (next year): | 91.57% |
Stock Insider Trading Activity of Verona Pharma plc (VRNA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Rickard Kathleen A. | VRNA | Chief Medical Officer | Mar 12 '25 | Sell | $8.35 | 79,264 | $661,941.59 | 2,608,976 |
Latest Verona Pharma plc News
VRNA Breaking Stock News: Dive into VRNA Ticker-Specific Updates for Smart Investing
MT Newswires
3 days ago
Verona Pharma Re-Works Loan Packages, Boosting Borrowing Capacity, Lowering Expense
GlobeNewswire
4 days ago
Verona Pharma Announces Amended Strategic Financing with Oaktree and OMERS
Insider Monkey
5 days ago
Jim Cramer Advises Caution on Verona Pharma (VRNA): “Risky – Sell Half and Let the Rest Ride”
Insider Monkey
17 days ago
Is Verona Pharma plc (VRNA) the Best Performing Growth Stock in 2025?
Insider Monkey
a month ago
Verona Pharma plc (VRNA): A Bull Case Theory
Zacks
a month ago
Beat the Market the Zacks Way: Verona, Visa, Starbucks in Focus
Simply Wall St.
a month ago
Earnings Beat: Verona Pharma plc (NASDAQ:VRNA) Just Beat Analyst Forecasts, And Analysts Have Been Lifting Their Forecasts
GuruFocus.com
a month ago
Verona Pharma PLC (VRNA) Q4 2024 Earnings Call Highlights: Strong Launch of Ohtuvayre Amid ...
Compare VRNA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "VRNA Verona Pharma plc - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.